PMID- 30308201 OWN - NLM STAT- MEDLINE DCOM- 20191121 LR - 20191121 IS - 1879-1891 (Electronic) IS - 0002-9394 (Linking) VI - 198 DP - 2019 Feb TI - Progression of Diabetic Microaneurysms According to the Internal Reflectivity on Structural Optical Coherence Tomography and Visibility on Optical Coherence Tomography Angiography. PG - 8-16 LID - S0002-9394(18)30573-7 [pii] LID - 10.1016/j.ajo.2018.09.031 [doi] AB - PURPOSE: To investigate the progression of diabetic microaneurysms (MAs) according to the spectral-domain optical coherence tomography (SD-OCT) and OCT angiography (OCTA) characteristics and to evaluate their influence on the retinal extracellular fluid accumulation at 1 year follow-up in patients with nonproliferative diabetic retinopathy (NPDR). DESIGN: Prospective, observational case series. METHODS: Fourteen patients with NPDR underwent SD-OCT and OCTA at the baseline and at 1 year follow-up. For all the selected MAs the visibility, the changes of internal reflectivity, graded as hyporeflective, moderate, or hyperreflective, and the extracellular fluid accumulation surrounding each MA on SD-OCT at 1 year were evaluated. The changes in terms of visualization at the level either of superficial (SCP) or deep (DCP) capillary plexus and the presence of flow on the corresponding OCTA scan at 1 year were evaluated. RESULTS: Of 127 MAs selected at the baseline, 89 (70%) were still visible on SD-OCT at 1 year. The reflectivity pattern at baseline was strongly associated with extracellular fluid accumulation at 1 year, with 18% of hyporeflective vs 66% of hyperreflective MAs developing extracellular fluid (P = .004). Among OCTA findings, the presence of flow (P = .001), the visibility (P < .001), and the deep location (DCP or both DCP and SCP, P = .007) were strongly associated with the development of extracellular fluid at 12 months. CONCLUSIONS: This study suggests an association between the SD-OCT and OCTA characteristics of diabetic MAs and the retinal extracellular fluid accumulation at 1 year. A better interpretation of MA characteristics could improve the timing and the management of diabetic maculopathy. CI - Copyright (c) 2018 Elsevier Inc. All rights reserved. FAU - Parravano, Mariacristina AU - Parravano M AD - IRCCS - Fondazione Bietti, Rome, Italy. FAU - De Geronimo, Daniele AU - De Geronimo D AD - IRCCS - Fondazione Bietti, Rome, Italy. FAU - Scarinci, Fabio AU - Scarinci F AD - IRCCS - Fondazione Bietti, Rome, Italy. FAU - Virgili, Gianni AU - Virgili G AD - Department of Translational Surgery and Medicine, Eye Clinic, University of Florence, Florence, Italy. FAU - Querques, Lea AU - Querques L AD - Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy. FAU - Varano, Monica AU - Varano M AD - IRCCS - Fondazione Bietti, Rome, Italy. FAU - Bandello, Francesco AU - Bandello F AD - Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy. FAU - Querques, Giuseppe AU - Querques G AD - Department of Ophthalmology, University Vita-Salute, IRCCS San Raffaele, Milan, Italy. Electronic address: giuseppe.querques@hotmail.it. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20181009 PL - United States TA - Am J Ophthalmol JT - American journal of ophthalmology JID - 0370500 SB - IM MH - Aged MH - Diabetes Mellitus, Type 2/complications MH - Diabetic Retinopathy/*diagnosis/diagnostic imaging MH - Disease Progression MH - Extracellular Fluid MH - Exudates and Transudates MH - Female MH - Fluorescein Angiography/*methods MH - Follow-Up Studies MH - Humans MH - Male MH - Microaneurysm/*diagnosis/diagnostic imaging MH - Middle Aged MH - Prospective Studies MH - Retinal Vessels/*diagnostic imaging MH - Subretinal Fluid MH - Tomography, Optical Coherence/*methods MH - Visual Acuity/physiology EDAT- 2018/10/12 06:00 MHDA- 2019/11/22 06:00 CRDT- 2018/10/12 06:00 PHST- 2018/08/03 00:00 [received] PHST- 2018/09/23 00:00 [revised] PHST- 2018/09/26 00:00 [accepted] PHST- 2018/10/12 06:00 [pubmed] PHST- 2019/11/22 06:00 [medline] PHST- 2018/10/12 06:00 [entrez] AID - S0002-9394(18)30573-7 [pii] AID - 10.1016/j.ajo.2018.09.031 [doi] PST - ppublish SO - Am J Ophthalmol. 2019 Feb;198:8-16. doi: 10.1016/j.ajo.2018.09.031. Epub 2018 Oct 9.